Covid-19 and Parkinsonism:
Gespeichert in:
Weitere Verfasser: | , , , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Cambridge, MA ; San Diego, CA
Academic Press, an imprint of Elsevier
2022
|
Ausgabe: | First edition |
Schriftenreihe: | International review of neurobiology
volume 165 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | xiv, 305 Seiten Illustrationen, Diagramme |
ISBN: | 9780323991735 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV048535836 | ||
003 | DE-604 | ||
005 | 20221116 | ||
007 | t | ||
008 | 221028s2022 a||| |||| 00||| eng d | ||
020 | |a 9780323991735 |c hardback |9 978-0-323-99173-5 | ||
035 | |a (OCoLC)1349540070 | ||
035 | |a (DE-599)BVBBV048535836 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
084 | |a YG 5500 |0 (DE-625)153506:12905 |2 rvk | ||
084 | |a YD 8600 |0 (DE-625)164057:12905 |2 rvk | ||
245 | 1 | 0 | |a Covid-19 and Parkinsonism |c edited by K Ray Chaudhuri, Mayela Rodríguez-Violante, Angelo Antonini, Iro Boura |
250 | |a First edition | ||
264 | 1 | |a Cambridge, MA ; San Diego, CA |b Academic Press, an imprint of Elsevier |c 2022 | |
300 | |a xiv, 305 Seiten |b Illustrationen, Diagramme | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a International review of neurobiology |v volume 165 | |
650 | 0 | 7 | |a Parkinsonismus |0 (DE-588)4173363-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a COVID-19 |0 (DE-588)1206347392 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a COVID-19 |0 (DE-588)1206347392 |D s |
689 | 0 | 1 | |a Parkinsonismus |0 (DE-588)4173363-0 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Chaudhuri, K. Ray |4 edt | |
700 | 1 | |a Rodríguez-Violante, Mayela |4 edt | |
700 | 1 | |a Antonini, Angelo |4 edt | |
700 | 1 | |a Boura, Iro |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-0-323-99174-2 |
830 | 0 | |a International review of neurobiology |v volume 165 |w (DE-604)BV002534817 |9 165 | |
856 | 4 | 2 | |m Digitalisierung UB Regensburg - ADAM Catalogue Enrichment |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033912456&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-033912456 |
Datensatz im Suchindex
_version_ | 1804184532900904960 |
---|---|
adam_text | Contents Contributors xi 1. Parkinsonism associated with viral infection 1 Irina Ivan, Laura Irincu, Ştefania Diaconu, and Cristian Falup-Pecurariu 2 1. Introduction 2. Epstein Barr virus 2 3. Hepatitis viruses 3 4. Human immunodeficiency virus 4 5. Herpes virus 5 6. Influenza/H1N1 6 7. Coxsackie virus 8 8. Flaviviruses 9 10 9. COVID-19 10. Conclusion 11 References 11 2. Covid-19, nervous system pathology, and Parkinson s disease: Bench to bedside 17 Aron Emmi, Iro Bourá, Vanessa Raeder, Donna Mathew, David Sulzer, James E. Goldman, and Valentina Leta 1. Introduction 18 2. SARS-CoV-2 receptors 18 3. Neuroinflammation in post-mortem Covid-19 brain 19 4. Little evidence of neuro-invasion in post-mortem Covid-19 cases 20 5. SARS-CoV-2 and parkinsonism 22 6. Peripheral pathways that may contribute to neuroinflammation 24 7. Conclusion 27 References 28 3. Prevalence and outcomes of Covid-19 in Parkinson s disease: Acute settings and hospital 35 Conor Fearon and Alfonso Fasano 1. Introduction 36 2. Why should PwP be more or less susceptible to Covid-19? 37 3. Covid-19 prevalence in Parkinson s disease 39 vl
vi Contents 4. Covid-19 outcomes in Parkinson s disease 44 5. Reported modulators of Covid-19 risk in Parkinson s disease 52 6. Conclusion 56 References 57 4. Covid-19 and Parkinson s disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism 63 Valentina Leta, Iro Bourá, Daniel J. van Wamelen, Mayela Rodriguez-Violante, Angelo Antonini, and Kallói Ray Chaudhuri 1. Introduction 64 2. The acute effects of SARS-CoV-2 infection in people with Parkinson s disease 65 3. Parkinson s disease and Long-COVID 70 4. Post-covid-19 cases of Parkinsonism 72 5. Conclusions 84 References 84 5. Smell deficits in COVID-19 and possible links with Parkinson s disease 91 Aron Emmi, Michele Sandre, Andrea Porzionato, and Angelo Antonini 1. Introduction 92 2. Clinical features of COVID-19 olfactory impairment 92 3. Neuropathology of COVID-19 olfactory impairment 94 4. Olfactory impairment in COVID-19 and parkinsonism 97 References 99 6. Spotlight on non-motor symptoms and Covid-19 103 Silvia Rota, Iro Bourá, Yi-Min Wan, Claudia Lazcano-Ocampo, Mayela Rodriguez-Violante, Angelo Antonini, and Kallo! Ray Chaudhuri 1. Introduction 104 2. Depression 105 3. Anxiety 106 4. Cognitive impairment 109 5. Psychosis 112 6. Delirium 113 7. Hyposmia 114 8. Gastrointestinal dysfunction 115 9. Dysautonomia 10. Pain 117 118
vii Contents 11. Fatigue 119 12. Sleep impairment 120 13. Conclusion 123 References 123 7. Treatment paradigms in Parkinson s Disease and Covid-19 135 Iro Bourá, Lucia Batzu, Espen Dietrichs, and Kallói Ray Chaudhuri 1. Introduction . 2. Management of PwP according to Covid-19 severity 136 137 3. Asymptomatic or mild Covid-19 infection 138 4. Moderate Covid-19 infection 144 5. Severe Covid-19 infection 152 6. Other pharmacological interventions .in Covid-19 and possible complications in PwP 155 7. Usual complications in hospitalized PwP and Covid-19 156 8. Conclusion 161 References 162 8. Covid-19 and Parkinson s disease: Nursing care, vaccination and impact on advanced therapies 173 Anna Roszmann, Aleksandra Μ. Podlewska, Yue Hui Lau, Iro Bourá, and Annette Hand 1. Introduction 174 2. The role of the Parkinson s disease nurse specialist 174 3. Covid-19 vaccinations 180 4. Impact on advanced therapies 184 References 191 9. Social isolation, loneliness and mental health sequelae of the Covid-19 pandemic in Parkinson s disease 197 Bradley McDaniels and Indu Subramanian 1. Introduction 2. Loneliness 198 3. Physiology of loneliness 201 4. Loneliness and the brain 202 5. General health effects of loneliness 202 6. Loneliness and mental and cognitive health 203 7. Loneliness and the aging population 203 8. Loneliness and chronic illness 204 198
viii Contents 9. Loneliness and Parkinson s disease 205 10. Non-motor aspects of Parkinson s disease 206 11. Covid-19 and Parkinson s disease 207 12. Next steps in addressing loneliness among PwP 208 13. Conclusion 214 References 215 10. Parkinson s disease and Covid-19: Is there an impact of ethnicity and the need for palliative care 229 Katarina Rukavina, Victor McConvey, Kallo! Ray Chaudhuri, and Janis Miyasaki 1. Palliative care: General principles and the importance for people with Parkinson s disease 230 2. Parkinson s disease and Covid-19: Morbidity and mortality 232 3. Increased vulnerability of Covid-19 in individuals from ethnic minority groups: Implications for Parkinson s disease 234 4. An increased need for palliative care pathways for people with Parkinson s disease during the Covid-19pandemic 235 5. Specific palliative care needs in people with Parkinson s disease during the 236 Covid-19 pandemic 6. Conclusions 244 References 244 11. COVID-19: The cynosure of riseof Parkinson s disease 251 Prashanth Lingappa Kukkle 1. Introduction « 251 2. Lessons from the past 252 3. Insights from the present 254 4. The post Covid-19 future 258 References 258 12. Parkinson s disease and Covid-19: The effect and use of telemedicine 263 Aleksandra Μ. Podlewska and Daniel J. van Wamelen 1. Introduction 264 2. Patient-facing services 265 3. Videoconferencing and assessments via video systems 267 4. Additional telemedicine assessments 267 5. Remote delivery of treatment 271 6. Wearable technologies 272
ix Contents 7. Patient education 273 8. Communication between professionals 274 9. Limitations and future of telehealth in Parkinson s disease 274 10. Conclusions 276 References 277 13. Impact of Covid-19 on research and training in Parkinson s disease 283 Yi-Min Wan, Daniel J. van Wamelen, Yue Hui Lau, Silvia Rota, and Eng-King Tan 1. Introduction 284 2. Research activities 284 3. Medical and specialty training 292 4. Mental health in researchand training 297 5. Conclusions 299 References 300
|
adam_txt |
Contents Contributors xi 1. Parkinsonism associated with viral infection 1 Irina Ivan, Laura Irincu, Ştefania Diaconu, and Cristian Falup-Pecurariu 2 1. Introduction 2. Epstein Barr virus 2 3. Hepatitis viruses 3 4. Human immunodeficiency virus 4 5. Herpes virus 5 6. Influenza/H1N1 6 7. Coxsackie virus 8 8. Flaviviruses 9 10 9. COVID-19 10. Conclusion 11 References 11 2. Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside 17 Aron Emmi, Iro Bourá, Vanessa Raeder, Donna Mathew, David Sulzer, James E. Goldman, and Valentina Leta 1. Introduction 18 2. SARS-CoV-2 receptors 18 3. Neuroinflammation in post-mortem Covid-19 brain 19 4. Little evidence of neuro-invasion in post-mortem Covid-19 cases 20 5. SARS-CoV-2 and parkinsonism 22 6. Peripheral pathways that may contribute to neuroinflammation 24 7. Conclusion 27 References 28 3. Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital 35 Conor Fearon and Alfonso Fasano 1. Introduction 36 2. Why should PwP be more or less susceptible to Covid-19? 37 3. Covid-19 prevalence in Parkinson's disease 39 vl
vi Contents 4. Covid-19 outcomes in Parkinson's disease 44 5. Reported modulators of Covid-19 risk in Parkinson's disease 52 6. Conclusion 56 References 57 4. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism 63 Valentina Leta, Iro Bourá, Daniel J. van Wamelen, Mayela Rodriguez-Violante, Angelo Antonini, and Kallói Ray Chaudhuri 1. Introduction 64 2. The acute effects of SARS-CoV-2 infection in people with Parkinson's disease 65 3. Parkinson's disease and Long-COVID 70 4. Post-covid-19 cases of Parkinsonism 72 5. Conclusions 84 References 84 5. Smell deficits in COVID-19 and possible links with Parkinson's disease 91 Aron Emmi, Michele Sandre, Andrea Porzionato, and Angelo Antonini 1. Introduction 92 2. Clinical features of COVID-19 olfactory impairment 92 3. Neuropathology of COVID-19 olfactory impairment 94 4. Olfactory impairment in COVID-19 and parkinsonism 97 References 99 6. Spotlight on non-motor symptoms and Covid-19 103 Silvia Rota, Iro Bourá, Yi-Min Wan, Claudia Lazcano-Ocampo, Mayela Rodriguez-Violante, Angelo Antonini, and Kallo! Ray Chaudhuri 1. Introduction 104 2. Depression 105 3. Anxiety 106 4. Cognitive impairment 109 5. Psychosis 112 6. Delirium 113 7. Hyposmia 114 8. Gastrointestinal dysfunction 115 9. Dysautonomia 10. Pain 117 118
vii Contents 11. Fatigue 119 12. Sleep impairment 120 13. Conclusion 123 References 123 7. Treatment paradigms in Parkinson's Disease and Covid-19 135 Iro Bourá, Lucia Batzu, Espen Dietrichs, and Kallói Ray Chaudhuri 1. Introduction . 2. Management of PwP according to Covid-19 severity 136 137 3. Asymptomatic or mild Covid-19 infection 138 4. Moderate Covid-19 infection 144 5. Severe Covid-19 infection 152 6. Other pharmacological interventions .in Covid-19 and possible complications in PwP 155 7. Usual complications in hospitalized PwP and Covid-19 156 8. Conclusion 161 References 162 8. Covid-19 and Parkinson's disease: Nursing care, vaccination and impact on advanced therapies 173 Anna Roszmann, Aleksandra Μ. Podlewska, Yue Hui Lau, Iro Bourá, and Annette Hand 1. Introduction 174 2. The role of the Parkinson's disease nurse specialist 174 3. Covid-19 vaccinations 180 4. Impact on advanced therapies 184 References 191 9. Social isolation, loneliness and mental health sequelae of the Covid-19 pandemic in Parkinson's disease 197 Bradley McDaniels and Indu Subramanian 1. Introduction 2. Loneliness 198 3. Physiology of loneliness 201 4. Loneliness and the brain 202 5. General health effects of loneliness 202 6. Loneliness and mental and cognitive health 203 7. Loneliness and the aging population 203 8. Loneliness and chronic illness 204 198
viii Contents 9. Loneliness and Parkinson's disease 205 10. Non-motor aspects of Parkinson's disease 206 11. Covid-19 and Parkinson's disease 207 12. Next steps in addressing loneliness among PwP 208 13. Conclusion 214 References 215 10. Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care 229 Katarina Rukavina, Victor McConvey, Kallo! Ray Chaudhuri, and Janis Miyasaki 1. Palliative care: General principles and the importance for people with Parkinson's disease 230 2. Parkinson's disease and Covid-19: Morbidity and mortality 232 3. Increased vulnerability of Covid-19 in individuals from ethnic minority groups: Implications for Parkinson's disease 234 4. An increased need for palliative care pathways for people with Parkinson's disease during the Covid-19pandemic 235 5. Specific palliative care needs in people with Parkinson's disease during the 236 Covid-19 pandemic 6. Conclusions 244 References 244 11. COVID-19: The cynosure of riseof Parkinson's disease 251 Prashanth Lingappa Kukkle 1. Introduction « 251 2. Lessons from the past 252 3. Insights from the present 254 4. The post Covid-19 future 258 References 258 12. Parkinson's disease and Covid-19: The effect and use of telemedicine 263 Aleksandra Μ. Podlewska and Daniel J. van Wamelen 1. Introduction 264 2. Patient-facing services 265 3. Videoconferencing and assessments via video systems 267 4. Additional telemedicine assessments 267 5. Remote delivery of treatment 271 6. Wearable technologies 272
ix Contents 7. Patient education 273 8. Communication between professionals 274 9. Limitations and future of telehealth in Parkinson's disease 274 10. Conclusions 276 References 277 13. Impact of Covid-19 on research and training in Parkinson's disease 283 Yi-Min Wan, Daniel J. van Wamelen, Yue Hui Lau, Silvia Rota, and Eng-King Tan 1. Introduction 284 2. Research activities 284 3. Medical and specialty training 292 4. Mental health in researchand training 297 5. Conclusions 299 References 300 |
any_adam_object | 1 |
any_adam_object_boolean | 1 |
author2 | Chaudhuri, K. Ray Rodríguez-Violante, Mayela Antonini, Angelo Boura, Iro |
author2_role | edt edt edt edt |
author2_variant | k r c kr krc m r v mrv a a aa i b ib |
author_facet | Chaudhuri, K. Ray Rodríguez-Violante, Mayela Antonini, Angelo Boura, Iro |
building | Verbundindex |
bvnumber | BV048535836 |
classification_rvk | YG 5500 YD 8600 |
ctrlnum | (OCoLC)1349540070 (DE-599)BVBBV048535836 |
discipline | Medizin |
discipline_str_mv | Medizin |
edition | First edition |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01906nam a2200445 cb4500</leader><controlfield tag="001">BV048535836</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20221116 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">221028s2022 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780323991735</subfield><subfield code="c">hardback</subfield><subfield code="9">978-0-323-99173-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1349540070</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048535836</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YG 5500</subfield><subfield code="0">(DE-625)153506:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YD 8600</subfield><subfield code="0">(DE-625)164057:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Covid-19 and Parkinsonism</subfield><subfield code="c">edited by K Ray Chaudhuri, Mayela Rodríguez-Violante, Angelo Antonini, Iro Boura</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">First edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, MA ; San Diego, CA</subfield><subfield code="b">Academic Press, an imprint of Elsevier</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 305 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">International review of neurobiology</subfield><subfield code="v">volume 165</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Parkinsonismus</subfield><subfield code="0">(DE-588)4173363-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">COVID-19</subfield><subfield code="0">(DE-588)1206347392</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">COVID-19</subfield><subfield code="0">(DE-588)1206347392</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Parkinsonismus</subfield><subfield code="0">(DE-588)4173363-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chaudhuri, K. Ray</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rodríguez-Violante, Mayela</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antonini, Angelo</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boura, Iro</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-0-323-99174-2</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">International review of neurobiology</subfield><subfield code="v">volume 165</subfield><subfield code="w">(DE-604)BV002534817</subfield><subfield code="9">165</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg - ADAM Catalogue Enrichment</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033912456&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033912456</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV048535836 |
illustrated | Illustrated |
index_date | 2024-07-03T20:53:48Z |
indexdate | 2024-07-10T09:40:51Z |
institution | BVB |
isbn | 9780323991735 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033912456 |
oclc_num | 1349540070 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | xiv, 305 Seiten Illustrationen, Diagramme |
publishDate | 2022 |
publishDateSearch | 2022 |
publishDateSort | 2022 |
publisher | Academic Press, an imprint of Elsevier |
record_format | marc |
series | International review of neurobiology |
series2 | International review of neurobiology |
spelling | Covid-19 and Parkinsonism edited by K Ray Chaudhuri, Mayela Rodríguez-Violante, Angelo Antonini, Iro Boura First edition Cambridge, MA ; San Diego, CA Academic Press, an imprint of Elsevier 2022 xiv, 305 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier International review of neurobiology volume 165 Parkinsonismus (DE-588)4173363-0 gnd rswk-swf COVID-19 (DE-588)1206347392 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content COVID-19 (DE-588)1206347392 s Parkinsonismus (DE-588)4173363-0 s DE-604 Chaudhuri, K. Ray edt Rodríguez-Violante, Mayela edt Antonini, Angelo edt Boura, Iro edt Erscheint auch als Online-Ausgabe 978-0-323-99174-2 International review of neurobiology volume 165 (DE-604)BV002534817 165 Digitalisierung UB Regensburg - ADAM Catalogue Enrichment application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033912456&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Covid-19 and Parkinsonism International review of neurobiology Parkinsonismus (DE-588)4173363-0 gnd COVID-19 (DE-588)1206347392 gnd |
subject_GND | (DE-588)4173363-0 (DE-588)1206347392 (DE-588)4143413-4 |
title | Covid-19 and Parkinsonism |
title_auth | Covid-19 and Parkinsonism |
title_exact_search | Covid-19 and Parkinsonism |
title_exact_search_txtP | Covid-19 and Parkinsonism |
title_full | Covid-19 and Parkinsonism edited by K Ray Chaudhuri, Mayela Rodríguez-Violante, Angelo Antonini, Iro Boura |
title_fullStr | Covid-19 and Parkinsonism edited by K Ray Chaudhuri, Mayela Rodríguez-Violante, Angelo Antonini, Iro Boura |
title_full_unstemmed | Covid-19 and Parkinsonism edited by K Ray Chaudhuri, Mayela Rodríguez-Violante, Angelo Antonini, Iro Boura |
title_short | Covid-19 and Parkinsonism |
title_sort | covid 19 and parkinsonism |
topic | Parkinsonismus (DE-588)4173363-0 gnd COVID-19 (DE-588)1206347392 gnd |
topic_facet | Parkinsonismus COVID-19 Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033912456&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV002534817 |
work_keys_str_mv | AT chaudhurikray covid19andparkinsonism AT rodriguezviolantemayela covid19andparkinsonism AT antoniniangelo covid19andparkinsonism AT bourairo covid19andparkinsonism |